Indication
Acinetobacter baumannii Bacteremia
1 clinical trial
4 products
Clinical trial
Cefiderocol and Ampicillin-sulbactam vs. Colistin or Colistin-meropenem for Carbapenem Resistant Acinetobacter Baumannii Bacteremia or Hospital-acquired Pneumonia: Controlled Clinical Study With Historical Controls (CASCADE)Status: Not yet recruiting, Estimated PCD: 2026-07-01
Product
CefiderocolProduct
Ampicillin-sulbactamProduct
ColistinProduct
Meropenem